2007 Cardiometabolic Health Congress | Agenda | CME Conference Schedule, Symposia

Home

•

Site Map

•

Useful Links

October 20-23, 2010 · Sheraton Boston Hotel · Boston, MA

Join Our Mailing List

2010 Congress Details

2009 Congress Details

2008 Congress Details

2007 Congress Details

2006 Congress Details

2009 Online CME Activity

Useful Links

Recommend This Site

Download the
2010 Program Brochure

2007 Cardiometabolic Health Congress: Agenda

Wednesday, September 26, 2007
2:00pm – 6:00pm	Registration
6:30pm – 8:30pm	Dinner Symposium Prandial Insulin and Cardiovascular Risk Presenters: Lawrence Blonde, MD; William Cefalu, MD; John Gerich, MD
Thursday, September 27, 2007
6:30am – 8:00am	Breakfast Symposium Cardiometabolic Risk Reduction: Novel Strategies for Achieving Lipid and Glycemic Targets Zachary Bloomgarden, MD; David Cohen, MD; Om Ganda, MD
8:00am – 8:15am	Opening Remarks Jay Skyler, MD
8:15am – 8:45am	Keynote Presentation: The Science Behind Insulin Resistance and Its Impact on Cardiometabolic Risk C. Ronald Kahn, MD
8:45am – 9:15am	Pharmacotherapy for the Management of Type 2 Diabetes Martin Abrahamson, MD
9:15am – 9:45am	Exercise as an Intervention to Reduce Cardiovascular Risk in Patients with Diabetes Ronald Sigal, MD
9:45am – 10:15am	Nutritional Interventions to Reduce Cardiometabolic Risk Judith Wylie-Rosett, EdD, RD
10:15am – 10:45am	Morning Break / Exhibit Hall
10:45am – 11:15am	Type 2 Diabetes: Interdicting Disease Progression Bernard Zinman, MD
11:15am – 11:45am	Preventing the Progression of Atherosclerosis in Type 2 Diabetes Henry Ginsberg, MD
11:45am – 12:30pm	Diabetes Prevention: Does it Work? Is it Worthwhile? Moderator: Jay Skyler, MD Panelists: Hertzel Gerstein, MD, Richard Kahn, PhD, Larry Leiter, MD, Richard Nesto, MD
12:30pm – 1:45pm	Lunch Symposium Cardiometabolic Risk Management: The Role of Insulin Therapy in Achieving Glycemic Control Presenters: Paresh Dandonna, MBBS; Jack Leahy, MD; Richard Nesto, MD Advances in Hypertension Management: The Role of Direct Renin Inhibition in Achieving Blood Pressure Control Presenters: Alan Gradman, MD; Kenneth Jamerson, MD; Matthew Weir, MD
2:00pm – 2:30pm	Physiologic Mechanisms of Obesity Samuel Klein, MD
2:30pm – 3:00pm	Is It Visceral or Ectopic Fat Deposition, or Is It Both? Kitt Falk Petersen, MD
3:00pm – 3:30pm	Afternoon Break / Exhibit Hall
3:30pm – 4:00pm	Effects of Adipose Tissue-Derived Cytokines on Cardiovascular Function and Structure Gökhan Hotamisligil, MD, PhD
4:00pm – 4:30pm	Pharmacotherapy for Obesity Management: Current Practice and Future Directions Louis Aronne, MD
4:30pm – 5:00pm	Bariatric Surgery: Patient Selection, Procedure Options, and Outcomes Matthew Hutter, MD
5:00pm	Closing Remarks Richard Nesto, MD
5:00pm – 6:30pm	Welcome Reception
6:30pm – 8:30pm	Dinner Symposium Emerging Concepts in Obesity Management: Integrated Neurohormonal Therapy Henry Ginsberg, MD, Michael Schwartz, MD, Steven Smith, MD
Friday, September 28, 2007
6:30am – 8:00am	Breakfast Symposia Expert Roundtable: Emerging Concepts in Cardiometabolic Risk Management Christie Ballantyne, MD; Thomas Giles, MD; Steven Haffner, MD; Daniel Rader, MD Cardiometabolic Risk Reduction: The Role of New Generation Beta-Blockade in Achieving Hypertension Control Presenters: George Bakris, MD; Gary Gibbons, MD; R. Preston Mason, PhD

8:00am – 8:15am	Opening Remarks Christie Ballantyne, MD

8:15am –8:45am	Keynote Presentation Atherosclerosis in Patients with Cardiometabolic Risk: New Findings Regarding Inflammation and Neovascularization Valentin Fuster, MD, PhD

8:45am – 9:15am	Diabetes and Atherosclerosis: Defining the Link and Opportunities for Intervention Jorge Plutzky, MD

9:15am – 9:45am	Biomarkers and Noninvasive Imaging: Useful, Hopeful, or Hype? Christie Ballantyne, MD

9:45am – 10:15am	Morning Break / Exhibit Hall

10:15am – 10:45am	Risk Assessment Models to Predict Multiple Cardiometabolic Risk Factors Peter Wilson, MD

10:45am – 11:15am	Hypertension Management in Patients with Diabetes and Cardiovascular Disease George Bakris, MD

11:15am – 11:45am	Antithrombotics for Patients with Increased Cardiometabolic Risk: What Do We Use and For How Long? Deepak Bhatt, MD

11:45am – 1:00pm	Lunch Symposia The Role of the Endocannabinoid System in the Management of Cardiometabolic Risk Presenters: Louis Aronne, MD; Deepak Bhatt, MD; Robert Eckel, MD Cardiovascular Risk Reduction: Controlling Dyslipidemia in Patients with Type 2 Diabetes Presenters: Henry Ginsberg, MD; Ronald Goldberg, MD; Michael Welch, MD

1:15pm – 2:15pm	Dyslipidemia: Controversies and Difficulties in Lipid Management Moderator: Robert Eckel, MD Panelists: Christie Ballantyne, MD; Henry Ginsberg, MD; Ronald Goldberg, MD; Daniel Rader, MD
2:15pm – 2:45pm	Lipid Management in Children with Type 1 or Type 2 Diabetes Larry Dolan, MD

2:45pm – 3:15pm	Afternoon Break / Exhibit Hall

3:15pm – 3:45pm	Glycemic Control in Children with Type 1 or Type 2 Diabetes Sonia Caprio, MD

3:45 – 4:15pm	Butting Out: Novel Smoking Cessation Strategies to Reduce Cardiometabolic Risk David Gonzales, PhD
4:15pm – 5:15pm	Cardiometabolic Risk Management in High Risk Populations: Medical Management and Lifestyle Modification Strategies Presenters: John Foreyt, PhD; Nancy Houston Miller, RN, BSN ; Scott Urquhart PA-C





5:15pm	Closing Remarks Christie Ballantyne, MD
6:00pm – 8:00pm	Dinner Symposium Reducing Residual Cardiovascular Risk by Lowering Triglycerides and Raising HDL-C Presenters: Christie Ballantyne, MD; Jorge Plutzky, MD; Frank Sacks, MD
Saturday, September 29, 2007
6:30am – 8:00am	Breakfast Symposium Beyond Hypertension Control: The Role of ARBs in the Management of Cardiometabolic Risk Presenters: Thomas Giles, MD; Byron Hoogwerf, MD; Willa Hsueh, MD

8:00am – 8:15am	Opening Remarks Robert Eckel, MD


8:15am – 8:45am	The Impact of Personalized Medicine on the Management of the Obese Patient with Multiple Cardiometabolic Risk Factors Allen Spiegel, MD

8:45am – 9:30am	Early Kidney Disease: The Underappreciated Cardiometabolic Risk Factor Robert Toto, MD
9:30am – 10:00am	The Influence of Genetics on Hypertension and Cardiometabolic Risk Management: Current Strategies and Future Directions Richard Lifton, MD
10:00am – 10:30am	Morning Break / Exhibit Hall

10:30am – 11:00am	Appropriate Revascularization in Patients with Diabetes and Cardiovascular Disease Richard Nesto, MD

11:00am – 12:00pm	Expert Roundtable: Evaluating Clinical Trial Evidence Moderator: Richard Nesto, MD Presenters: Christie Ballantyne, MD; Robert Eckel, MD; Steven Haffner, MD

12:00pm – 1:00pm	Lunch Symposium Establishing the Relationship between Erectile Dysfunction and Cardiometabolic Risk: Opportunities for Screening and Early Intervention to Improve Patient Care Presenters: Andrew McCullough, MD; R. Parker Ward, MD
1:00pm	Closing Remarks Robert Eckel, MD

Dyslipidemia Conference • Hypertension Conference • Type 2 Diabetes Conference • Insulin Resistance Conference • Obesity Conference